NCCAM Director leaves
This article was originally published in The Tan Sheet
Executive SummaryThe National Center for Complimentary and Alternative Medicine announces Nov. 7 Director Stephen E. Straus, M.D., stepped down from his leadership of NCCAM for health reasons. According to the Center, Straus will become Senior Adviser to National Institutes of Health Director Elias A. Zerhouni, M.D. Under Straus' leadership, CAM research at NIH grew threefold, according to the center. "Dr. Straus led the evolution of CAM science beyond the advocacy and skepticism and polarization it once engendered to earn legitimacy as a research area," a release says. Zerhouni named Ruth L. Kirschstein, M.D., the acting NCCAM director...
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.